November 19, 2021
A key health ministry advisory panel will take up a batch of new medicines for review on December 2, including Amgen’s KRAS G12C inhibitor sotorasib and MSD’s cough medicine gefapixant. The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee...read more